T1	Participants 444 597	Patients with locally advanced or metastatic head and neck squamous cell carcinoma or nasopharyngeal carcinoma not suitable for operation or radiotherapy
T2	Participants 730 797	One hundred and thirty-six eligible patients were randomly assigned
